Difference between revisions of "Marchetti P"
From Bioblast
Line 2: | Line 2: | ||
|lastname=Marchetti | |lastname=Marchetti | ||
|firstname=P | |firstname=P | ||
| | |institution=Department of Physiology | ||
Univ. Droit et Sante - Lille II | Univ. Droit et Sante - Lille II | ||
Line 8: | Line 8: | ||
Faculte de Medecine H. Warembourg | Faculte de Medecine H. Warembourg | ||
1 place de Verdun | |address=1 place de Verdun | ||
Β | |area code=59045 | ||
|city=Lille cedex | |||
|country=France | |||
}} | |||
{{Labelingperson | |||
|field of research=Basic | |||
}} | }} |
Revision as of 12:26, 19 May 2015
Name | Marchetti P, |
---|---|
Institution | Department of Physiology
Univ. Droit et Sante - Lille II Faculte de Medecine H. Warembourg |
Address | 1 place de Verdun, 59045 |
City | Lille cedex |
State/Province | |
Country | France |
Weblink | |
O2k-Network Lab | FR Fort de France Neviere R |
Labels:
Field of research: Basic
Publications
Published | Reference | |
---|---|---|
Germain 2019 Int J Med Sci | 2019 | Germain N, Dessein AF, Vienne JC, Dobbelaere D, Mention K, Joncquel M, Dekiouk S, Laine W, Kluza J, Marchetti P (2019) First-line screening of OXPHOS deficiencies using microscale oxygraphy in human skin fibroblasts: A preliminary study. Int J Med Sci 16:931-38. |
Oliveira 2015 Biotechniques | 2015 | Oliveira AF, Cunha DA, Ladriere L, Igoillo-Esteve M, Bugliani M, Marchetti P, Cnop M (2015) In vitro use of free fatty acids bound to albumin: A comparison of protocols. Biotechniques 58:228-33. |
Seillier 2015 EMBO Mol Med | 2015 | Seillier M, Pouyet L, N'Guessan P, Nollet M, Capo F, Guillaumond F, Peyta L, Dumas JF, Varrault A, Bertrand G, Bonnafous S, Tran A, Meur G, Marchetti P, Ravier MA, Dalle S, Gual P, Muller D, Rutter GA, Servais S, Iovanna JL, Carrier A (2015) Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1. EMBO Mol Med 7:802-18. |
Kluza 2011 PLoS One | 2011 | Kluza J, Jendoubi M, Ballot C, Dammak A, Jonneaux A, Idziorek T, Joha S, Dauphin V, Malet-Martino M, Balayssac S, Maboudou P, Briand G, Formstecher P, Quesnel B, Marchetti P (2011) Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells. PLoS One 6:e21924 |
Marechal 2011 Clin Sci (Lond) | 2011 | Marechal X, Montaigne D, Marciniak C, Marchetti P, Hassoun SM, Beauvillain JC, Lancel S, Neviere R (2011) Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics. Clin Sci (Lond) 121:405-13. |
Montaigne 2010 Toxicol Appl Pharmacol | 2010 | Montaigne D, Marechal X, Baccouch R, Modine T, Preau S, Zannis K, Marchetti P, Lancel S, Neviere R (2010) Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart. Toxicol Appl Pharmacol 244:300-7. |
Ballot 2010 Apoptosis | 2010 | Ballot C, Kluza J, Lancel S, Martoriati A, Hassoun SM, Mortier L, Vienne JC, Briand G, Formstecher P, Bailly C, Nevière R, Marchetti P (2010) Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D. Apoptosis 15:769-81. |
Larche 2006 J Am Coll Cardiol | 2006 | Larche J, Lancel S, Hassoun SM, Favory R, Decoster B, Marchetti P, Chopin C, Neviere R (2006) Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality. J Am Coll Cardiol 48:377-85. |
Hassoun 2006 Mitochondrion | 2006 | Hassoun SM, Lancel S, Petillot P, Decoster B, Favory R, Marchetti P, Neviere R (2006) Sphingosine impairs mitochondrial function by opening permeability transition pore. Mitochondrion 6:149-54. |